ISRG
63
-3
MDLZ
22
-16
MU
62
-6
CMA
73
-4
STI
11
-2
ORCL
26
-4
DG
74
-2
HP
42
-7
HAS
61
-5
NWS
46
-2
AME
65
-6
SEE
56
3
GM
83
-3
CCL
65
-3
BF.B
59
-2
COST
48
-2
PEG
50
-3
ROP
38
-10
NDAQ
73
-2
PNC
76
-6
ISRG
63
-3
MDLZ
22
-16
MU
62
-6
CMA
73
-4
STI
11
-2
ORCL
26
-4
DG
74
-2
HP
42
-7
HAS
61
-5
NWS
46
-2
AME
65
-6
SEE
56
3
GM
83
-3
CCL
65
-3
BF.B
59
-2
COST
48
-2
PEG
50
-3
ROP
38
-10
NDAQ
73
-2
PNC
76
-6
Financhill
Back

The Descartes Systems Group, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
73

DSGX
The Descartes Systems Group, Inc.

Last Price:
$90.67
Seasonality Move:
23.6%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Buy
73
The Descartes Systems Group, Inc. (DSGX) is a Buy

Is The Descartes Systems Group, Inc. a Buy, Sell or Hold?

  • The current The Descartes Systems Group, Inc. [DSGX] share price is $90.71. The Score for DSGX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • DSGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DSGX Stock Price Chart

What is The Descartes Systems Group, Inc.'s stock price today?

  • The The Descartes Systems Group, Inc. share price today is $90.71
    The current trend is moderately bullish and DSGX is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

DSGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 56.8 Buy
Chaikin Money Flow: -207650 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.01 - 89.93) Buy
Bollinger Bands (100): (87.27 - 103.51) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

DSGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.4 Sell
20-day SMA: 85.37 Buy
50-day SMA: 89.34 Buy
200-day SMA: 99.91 Sell
8-day EMA: 90.47 Buy
20-day EMA: 88.02 Buy
50-day EMA: 89.58 Buy
200-day EMA: 97.81 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

The Descartes Systems Group, Inc. Earnings Growth & DSGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.62 per share, and an increase next year of $0.26 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

The Descartes Systems Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):